 Comparative protective activity human monoclonal hyperimmune polyclonal antibody group streptococci Group streptococcal GBS infections significant morbidity mortality neonates compromised hosts opsonic antibody infecting strain conventional immunoglobulin preparations little GBS antibody protective activity human monoclonal antibody HuMAb human hyperimmune intravenous immunoglobulin HivIg organisms conventional intravenous immunoglobulin ivIg HuMAb HivIg significant protective activity virulent strains types II III GBS doses low mg/kg contrast conventional ivIg little protective activity strains doses high mg/kg opsonic activity HuMAb HivIg conventional ivIg studies HivIg HuMAb specific activity optimal immunotherapy GBS infections